General Information of the Compound
Compound ID
CP0341975
Compound Name
N-[[3-(cyclopenten-1-yl)phenyl]methyl]-2-[(2,2-dimethyl-3H-1-benzofuran-7-yl)oxy]ethanamine
    Show/Hide
Synonyms
D2/D3 antagonists (psychosis/schizophrenia), Pierre Fabre
F-15063
    Show/Hide
Structure
Formula
C24H29NO2
Molecular Weight
363.501
Canonical SMILES
CC1(C)Cc2cccc(OCCNCc3cccc(c3)C3=CCCC3)c2O1
    Show/Hide
InChI
InChI=1S/C24H29NO2/c1-24(2)16-21-11-6-12-22(23(21)27-24)26-14-13-25-17-18-7-5-10-20(15-18)19-8-3-4-9-19/h5-8,10-12,15,25H,3-4,9,13-14,16-17H2,1-2H3
    Show/Hide
InChIKey
RAIDOKRWKAIHOH-UHFFFAOYSA-N
Physicochemical Property
logP
5.136
Rotatable Bonds
7
Heavy Atom Count
27
Polar Areas
30.49
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
3
Complexity
27

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 10248159
SID: 15251277
ChEMBL ID
CHEMBL218261
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  1
1
EC50 = 10 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( F-15063 )
Drug Name F-15063
Company Centre de Recherche Pierre Fabre
Indication
Schizophrenia
Preclinical
Target(s)
Dopamine D3 receptor (D3R)
Modulator
Dopamine D2 receptor (D2R)
Modulator